Garry Niedermayer Selected Research

tenilsetam

1/2018

Investigation Into the Effects of Tenilsetam on Markers of Neuroinflammation in GFAP-IL6 Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Garry Niedermayer Research Topics

Disease

4	Neuroinflammatory Diseases 01/2021 - 04/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 04/2017
2	Inflammation (Inflammations) 01/2020 - 01/2013
1	Gliosis 01/2020
1	Vitamin D Deficiency 01/2013
1	Dementia (Dementias) 01/2013
1	Mental Disorders (Mental Disorder) 01/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Amyloid Plaque 01/2013

Drug/Important Bio-Agent (IBA)

2	Glial Fibrillary Acidic ProteinIBA 01/2021 - 01/2013
2	CytokinesIBA 01/2020 - 04/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2013
2	CurcuminIBA 01/2020 - 04/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	ApigeninIBA 01/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020
1	AntioxidantsIBA 01/2020
1	LecithinsIBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	tenilsetamIBA 01/2018
1	VitaminsIBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Vitamin D FDA LinkGeneric 01/2013
1	Interleukin-10 (Interleukin 10)IBA 01/2013
1	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 01/2013